# Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill Patients

> **NCT01744431** · — · COMPLETED · sponsor: **HaEmek Medical Center, Israel** · enrollment: 400 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01744431
- **Lead sponsor:** HaEmek Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2015-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01744431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01744431, "Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01744431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*